Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mtruong34's Profile
Displaying 351-400 of 505 result(s).
CYDY CytoDyn Inc
12/08/2020 1:01:00 AM
Some potential good news for Cytody (8)
CYDY CytoDyn Inc
12/04/2020 7:53:02 PM
Closet, I am in 100% agreement with (3)
CYDY CytoDyn Inc
12/04/2020 5:45:57 PM
Touché
CYDY CytoDyn Inc
12/04/2020 4:48:42 PM
Look at history for the answer. Whe (4)
CYDY CytoDyn Inc
12/04/2020 12:54:46 AM
FDA looking more like an embarrassm (1)
CYDY CytoDyn Inc
12/03/2020 10:18:56 PM
Cdiddy, The Marik protocol is the b (7)
CYDY CytoDyn Inc
11/30/2020 8:12:14 PM
MESO didn't change and are still go
CYDY CytoDyn Inc
11/25/2020 3:17:22 PM
IMO, Dr. Jay Lalezari would be the (5)
CYDY CytoDyn Inc
11/25/2020 9:26:41 AM
I would tend to agree with you. Bef (8)
CYDY CytoDyn Inc
11/25/2020 9:21:27 AM
Itolizumab, another mab from India, (1)
CYDY CytoDyn Inc
11/25/2020 9:05:59 AM
Cytodyn being very careful about ta (9)
CYDY CytoDyn Inc
11/24/2020 8:43:03 PM
WOW. EUA for no efficacy and leronl (5)
CYDY CytoDyn Inc
11/24/2020 2:26:32 PM
A comment about the PR regarding am (6)
CYDY CytoDyn Inc
11/23/2020 9:01:32 PM
Because Cytodyn is a small company
CYDY CytoDyn Inc
11/23/2020 8:16:53 PM
Agreed. Even though we haven't seen (1)
CYDY CytoDyn Inc
11/23/2020 7:29:26 PM
Dr. BP had a few interesting commen (1)
CYDY CytoDyn Inc
11/23/2020 4:35:35 PM
OK gotcha. So NP is saying if we re (2)
CYDY CytoDyn Inc
11/23/2020 4:17:23 PM
In today's Proactiv video, NP menti
CYDY CytoDyn Inc
11/23/2020 2:37:09 PM
I'm most interested to have a CC/we (2)
CYDY CytoDyn Inc
11/20/2020 8:13:20 PM
Anyone know how long does it typica
CYDY CytoDyn Inc
11/20/2020 1:06:14 AM
otcaddict, I was not referring to r
CYDY CytoDyn Inc
11/20/2020 12:45:14 AM
The primary objective of this phase
CYDY CytoDyn Inc
11/19/2020 8:57:25 PM
FDA keeps pulling them along though (1)
CYDY CytoDyn Inc
11/19/2020 8:02:03 PM
The fact that leronlimab is going t
CYDY CytoDyn Inc
11/19/2020 4:45:05 PM
The doctor administering the Ph2 Co (6)
CYDY CytoDyn Inc
11/19/2020 3:08:05 PM
Yes, although this Senate hearing w (2)
CYDY CytoDyn Inc
11/19/2020 2:35:46 PM
This hearing is a positive for all
CYDY CytoDyn Inc
11/19/2020 2:25:08 PM
https://www.youtube.com/watch?v=EJ (3)
CYDY CytoDyn Inc
11/17/2020 2:39:31 PM
In today's Proactiv video, NP menti (10)
CYDY CytoDyn Inc
11/17/2020 12:58:23 PM
While we all wait for the approval
CYDY CytoDyn Inc
11/16/2020 1:53:26 PM
Seems like UK enrollment won't make (4)
CYDY CytoDyn Inc
11/15/2020 1:23:06 PM
Ha. NP that wiley fox. Links to an
CYDY CytoDyn Inc
11/13/2020 4:49:04 PM
Did Trump also say that AstraZeneca
CYDY CytoDyn Inc
11/12/2020 9:25:33 PM
Evilbrt, for the record, I personal (2)
CYDY CytoDyn Inc
11/12/2020 8:48:50 PM
Yes, I was referring to EUA, not fu (1)
CYDY CytoDyn Inc
11/12/2020 8:11:05 PM
I think the reason the LH protocol (8)
CYDY CytoDyn Inc
11/11/2020 10:19:36 PM
1. Wonder what "very powerful thera (2)
CYDY CytoDyn Inc
11/11/2020 10:02:26 PM
I also have the same observation. S (5)
CYDY CytoDyn Inc
11/11/2020 8:29:05 PM
It would be great if your family me (1)
CYDY CytoDyn Inc
11/11/2020 8:21:47 PM
Yes, that is my observation as well (2)
CYDY CytoDyn Inc
11/11/2020 5:19:27 PM
I don't think we will have a repeat
CYDY CytoDyn Inc
11/11/2020 5:14:18 PM
I've thought about 28 vs 42 and 75% (2)
CYDY CytoDyn Inc
11/11/2020 4:07:01 PM
In today's Proactive video, Nader m (2)
CYDY CytoDyn Inc
11/10/2020 4:21:24 PM
Dumbest analogy ever. That m/m pie (2)
CYDY CytoDyn Inc
11/10/2020 3:16:43 PM
Pfizer's DSMC basically said in the (3)
CYDY CytoDyn Inc
11/10/2020 2:44:15 PM
CDiddy, respectfully disagree. Covi (5)
CYDY CytoDyn Inc
11/10/2020 12:43:12 PM
Wrong MarcS. Cytodyn linked another (1)
CYDY CytoDyn Inc
11/10/2020 12:23:36 PM
A competent CEO would have filed fo (5)
CYDY CytoDyn Inc
11/10/2020 12:07:35 PM
Also, eIND results can't be discoun (1)
CYDY CytoDyn Inc
11/10/2020 11:58:15 AM
I wonder if CYDY will link Dr. Patt (2)
Go to page:
  • << First
  • < Previous
  • 7
  • 8
  • Next >

Recent Articles

  • Investigation into United Natural Foods Inc. Securities Practices
  • Understanding T. Rowe Price Group's Earnings Expectations
  • RacquetDesk Enhances Club Management with Swish Integration
  • Revolutionizing Performance Management with Applause Scorecards
  • Insights on Franklin Resources' Upcoming Earnings Report
  • SMT Energy Launches Innovative Battery Storage Project in Texas
  • Growth and Innovations in Biosurgery Market for Future Success
  • Anticipating Fortis Quarterly Earnings: Key Insights Ahead
  • Exploring Growth Trends in the Cloud OSS BSS Sector
  • Shell PLC's Financial Performance and Market Insights for 2025
  • Lick's New Scented Bath Oils: Elevate Your Bath Ritual Today
  • Blockchain Technology Transformation: Future Growth Prospects
  • Navigating Legal Waters: PepGen Inc. Securities Legal Action
  • Georgia Power Seeks Approval for Massive Energy Resource Expansion
  • Dream Pairs Achieves Landmark Victory in Trademark Litigation
  • CPSC Urges Immediate Action on Unsafe Hair Growth Products
  • Funding Boost for Stablecoin-Focused Blockchain Project
  • Scripps Strengthens Research Initiatives with Strategic Hire
  • Advantech Unveils Cutting-Edge AI Solutions at Chicago Expo
  • Global Menopause Awareness: Insights from a New Report
  • Investors Alert: Join the Fiserv, Inc. Class Action Now
  • Mastercard's Strong Q2 Performance: Future Growth Insights
  • The Impact of Rising Consumer Confidence on Retail Stocks
  • Aluminum Nitride Market Booms with Demand for Thermal Conductivity
  • Exploring the Future of Healthcare Analytical Testing Services
  • Metallized BOPP Films Market: Insights and Future Growth
  • Exploring the Remote Operated Vehicle Surge and Market Dynamics
  • Projected Growth of Diabetes Care Devices to $76.44 Billion
  • Innovative ELNO Presale Offers Early Bird Tokens at $0.05 Each
  • Maximize Your Trading Potential with BexBack's New Offers
  • Insights from Encore Capital Group's Latest Economic Freedom Study
  • Innovative Collaboration in Longevity Science Unveiled
  • Silexion Therapeutics Unveils Promising Results in Cancer Research
  • iRocket's $400M SPAC Deal Opens New Spacefront Opportunities
  • Exploring Top Financial Stocks with Exceptional Dividend Yields
  • PREMIUM Development's FIFTEEN Apartments Achieves Remarkable Sales Success
  • Virtus Capital Welcomes Alexander Steele to Executive Team
  • Immunophotonics Advances Cancer Treatment with IP-001 Trial Completion
  • Join the Call: Vestis Corp Securities Fraud Opportunity Ahead
  • Exciting Announcements for the Upcoming Designed for Life Event
  • New Insights into Oral Microbiome and Immune Challenges
  • Whataburger Celebrates Summer with New Blackberry Shake
  • Brightspeed Wins Prestigious Award for Innovative Connectivity
  • Aniai Transforms Grill Maintenance with Predictive Technologies
  • Navigating the Markets: Are Record Highs Sustainable for Investors?
  • Red Cat Holdings: An Emerging Leader in Drone Technology
  • Koryx Copper Completes $25 Million Financing to Advance Haib Project
  • Exploring the Kombucha Market's Bold Path to $5.9 Billion
  • Eli Lilly's Mounjaro Outperforms Trulicity in Latest Study
  • Laurentide Controls Partners with Danfoss to Boost Operations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site